Psychedelic Brain · 迷幻研究文獻日報 · 2026年6月22日（週一）

⭐今日精選 TOP Picks

#1 🔬 中實用性

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

Journal of affective disorders · The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

INTRODUCTION: The contribution of patient support to psilocybin's antidepressant effects remains uncertain. METHODS: Relationships between therapeutic alliance (Scale to Assess Therapeutic Relationshi

PsilocybinPsychedelic experiencePsychological support 閱讀原文 →

#2 🔬 中實用性

Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.

ACS chemical neuroscience · Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.

Psychedelics have re-emerged as promising therapeutics for neuropsychiatric disorders, including depression, anxiety, post-traumatic stress disorder, and substance use disorders. While their beneficia

5-HT2Along-actingpsilocybin 閱讀原文 →

#3 🔬 中實用性

Psychometric validation of the French version of the five-dimensional altered states of consciousness questionnaire (5D-ASC) and associated 11 OAV subscales.

Progress in neuro-psychopharmacology & biological psychiatry · Psychometric validation of the French version of the five-dimensional altered states of consciousness questionnaire (5D-ASC) and associated 11 OAV subscales.

INTRODUCTION: The renewal of psychedelic medicine has garnered significant scientific interest, with large efforts dedicated to the understanding of the complex subjective experiences induced by these

5D-ASCAltered states of consciousness questionnaireConsciousness alteration 閱讀原文 →

#4 🔬 中實用性

Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling.

European journal of pharmacology · Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling.

Major Depressive Disorder (MDD) is a debilitating mental health condition that significantly impacts quality of life. Despite available pharmacological treatments, response rates remain suboptimal, wi

5-HT2A receptorAntidepressant actionG protein-coupled receptors 閱讀原文 →

📋 今日文獻趨勢

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.

Psychometric validation of the French version of the five-dimensional altered states of consciousness questionnaire (5D-ASC) and associated 11 OAV subscales.

Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling.